CD4+T can promote the activation of CD8+CTLs, boost the effector and memory functions of CTLs, and reduce the immunosuppression of CTLs, which helps T cells amplify their response to tumor-associated antigens without generating an autoimmune response [44]. The gene discussed is CD4; the disease is neoplasm.